Medicofarma Biotech SA issues two MAR Article 19(1) notifications

Medicofarma Biotech SA has filed two notifications regarding transactions by persons discharging managerial responsibilities under the EU Market Abuse Regulation. These filings typically indicate insider trading activity or changes in significant shareholdings, though specific details on the nature of the transactions remain undisclosed in the source.